Parenteral application

Injectables often consist of molecules that cannot be administered directly into the bloodstream due to their sensitivity to oxidation. Typically, these molecules are delivered in emulsions, which can lead to long-term chemical and physical instability, as well as other drawbacks. LDS addresses these challenges by loading the active molecules onto its novel nano-domains, offering solutions to the disadvantages associated with injectable emulsions. These solutions include thermodynamic stability, reduced pain upon injection, improved solubility, and enhanced activity.

PK in Dogs: NEOPROL formulations (NP09) Demonstrating bio-equivalence to commercial product